Uro-Oncology Clinic

Prostate Cancer Diagnosis and Management

• Multiparametric MRI prostate for lesion detection and characterisation

• MRI-targeted and systematic transrectal and transperineal prostate biopsy

• PSA monitoring and prostate cancer risk stratification

• Active surveillance programme for low-risk prostate cancer

• Robotic-assisted radical prostatectomy for clinically localised prostate cancer

• Laparoscopic radical prostatectomy for eligible patients

• Pelvic lymph node dissection for intermediate and high-risk disease

• Radiation therapy coordination including external beam radiotherapy and brachytherapy

• Hormonal therapy for locally advanced and metastatic prostate cancer

• Castration-resistant prostate cancer management with enzalutamide and abiraterone

• PSMA PET-CT for biochemical recurrence and metastatic staging

• Bone health management and denosumab therapy for metastatic bone disease

Bladder Cancer Diagnosis and Management

• Flexible cystoscopy and rigid cystoscopy for bladder tumour evaluation

• Transurethral resection of bladder tumour for non-muscle-invasive bladder cancer

• Blue light and narrow band imaging cystoscopy for enhanced tumour detection

• Intravesical BCG immunotherapy for high-risk non-muscle-invasive bladder cancer

• Intravesical chemotherapy for intermediate-risk bladder cancer

• Radical cystectomy and urinary diversion for muscle-invasive bladder cancer

• Robotic-assisted radical cystectomy for eligible patients

• Neobladder construction and ileal conduit urinary diversion

• Neoadjuvant chemotherapy coordination before radical cystectomy

• Systemic chemotherapy and immunotherapy for advanced and metastatic bladder cancer

Kidney Cancer Diagnosis and Management

• Renal mass evaluation using CT and MRI with renal mass protocol imaging

• Percutaneous renal biopsy for histological characterisation of renal masses

• Active surveillance for small renal masses meeting criteria

• Robotic-assisted partial nephrectomy for nephron-sparing surgery

• Radical nephrectomy for large and locally advanced renal tumours

• Laparoscopic and open nephrectomy for renal cell carcinoma

• Inferior vena cava tumour thrombus surgery in coordination with vascular surgery

• Ablative therapies including radiofrequency ablation for small renal masses

• Targeted therapy with sunitinib, pazopanib and cabozantinib for metastatic RCC

• Immunotherapy with nivolumab and pembrolizumab for advanced renal cell carcinoma

• Cytoreductive nephrectomy for selected metastatic renal cancer patients

Testicular Cancer Diagnosis and Management

• Testicular ultrasound and tumour marker evaluation for testicular mass assessment

• Radical orchidectomy for testicular cancer diagnosis and treatment

• Staging CT chest abdomen and pelvis for lymph node and metastatic evaluation

• Active surveillance for Stage I seminoma and non-seminomatous germ cell tumours

• Carboplatin chemotherapy for Stage I seminoma adjuvant therapy

• BEP chemotherapy for metastatic and high-risk testicular germ cell tumours

• Retroperitoneal lymph node dissection for residual masses following chemotherapy

• Sperm banking prior to chemotherapy for fertility preservation

• Long-term testicular cancer surveillance and survivorship support

Upper Urinary Tract Urothelial Cancer

• Upper urinary tract urothelial carcinoma evaluation using CT urography

• Ureteroscopy and biopsy for upper tract lesion characterisation

• Nephroureterectomy with bladder cuff excision for upper tract urothelial cancer

• Laparoscopic and robotic nephroureterectomy for minimally invasive resection

• Segmental ureterectomy for selected distal ureteric tumours

• Instillation therapy for low-grade upper tract tumours

• Surveillance cystoscopy and urinary cytology following nephroureterectomy

Penile Cancer Management

• Penile cancer evaluation and staging including inguinal lymph node assessment

• Organ-preserving penile surgery for distal penile tumours

• Partial and total penectomy for advanced penile malignancy

• Inguinal lymph node dissection for nodal staging and treatment

• Sentinel lymph node biopsy for clinically node-negative penile cancer

• Radiation therapy coordination for selected penile cancer cases

• Reconstructive surgery coordination with plastic surgery for penile rehabilitation

Adrenal Tumour Management

• Adrenal mass evaluation including CT, MRI and functional endocrine testing

• Adrenocortical carcinoma evaluation and surgical management

• Phaeochromocytoma and paraganglioma surgical management

• Laparoscopic adrenalectomy for benign and selected malignant adrenal tumours

• Open adrenalectomy for large and complex adrenal malignancies

• Coordination with endocrinology for perioperative hormonal management

• Long-term adrenal tumour surveillance following adrenalectomy

Uro-Oncology Tumour Board and Multidisciplinary Planning

• Regular uro-oncology multidisciplinary tumour board meetings

• Complex case review involving urology, oncology, radiology and pathology

• Personalised treatment plan development based on tumour board recommendations

• Second opinion service for complex and treatment-resistant urological cancers

• Clinical trial eligibility assessment for novel uro-oncology therapies

• Genomic profiling and molecular tumour characterisation for treatment personalisation

Systemic Therapy for Advanced Urological Cancers

• Platinum-based chemotherapy for bladder and germ cell tumours

• Targeted therapy including VEGFR and mTOR inhibitors for renal cell carcinoma

• Androgen deprivation therapy and novel hormonal agents for prostate cancer

• Immune checkpoint inhibitor immunotherapy for urothelial and renal cancers

• PARP inhibitor therapy for BRCA-mutated prostate cancer

• Bone-targeted therapy for metastatic prostate cancer with bone involvement

• Coordination with Moolchand Cancer Institute for integrated systemic oncology management

Radiation Oncology for Urological Cancers

• External beam radiotherapy for prostate cancer as definitive or adjuvant treatment

• Stereotactic body radiotherapy for localised prostate and oligometastatic renal cancer

• Brachytherapy for selected prostate cancer cases

• Palliative radiotherapy for bone metastases and symptomatic disease

• Coordination with radiation oncology for integrated multimodality uro-oncology care

Uro-Oncology Survivorship and Follow-Up Programme

• Structured post-treatment surveillance programme for all urological cancer survivors

• PSA monitoring and recurrence detection following prostate cancer treatment

• Surveillance cystoscopy and urinary cytology following bladder cancer treatment

• Renal function monitoring following nephrectomy

• Fertility counselling and sexual function rehabilitation following uro-oncological surgery

• Psychological support and quality of life assessment for cancer survivors

• Long-term surveillance imaging and tumour marker monitoring